OptiBiotix Health PLC (LON:OPTI)‘s stock had its “corporate” rating reiterated by investment analysts at FinnCap in a research note issued to investors on Wednesday, November 1st.
OptiBiotix Health PLC (LON:OPTI) traded down GBX 2 ($0.03) during midday trading on Wednesday, reaching GBX 70 ($0.92). 220,406 shares of the company’s stock traded hands, compared to its average volume of 160,212. OptiBiotix Health PLC has a 12-month low of GBX 59 ($0.78) and a 12-month high of GBX 90 ($1.18).
COPYRIGHT VIOLATION NOTICE: “OptiBiotix Health PLC (OPTI) Stock Rating Reaffirmed by FinnCap” was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece on another website, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece can be read at https://www.dispatchtribunal.com/2017/11/18/finncap-reiterates-corporate-rating-for-optibiotix-health-plc-opti.html.
OptiBiotix Health PLC Company Profile
Optibiotix Health Plc is a life sciences company developing a range of products to modify the human microbiome. The Company’s principal activity is research and development into microbiome modulators. It operates in UK segment. The Company has a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression.
Receive News & Ratings for OptiBiotix Health PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiBiotix Health PLC and related companies with MarketBeat.com's FREE daily email newsletter.